Causes of QT Prolongation
QT interval prolongation is primarily caused by medications, electrolyte abnormalities, cardiac conditions, and genetic factors, with medications being the most frequent cause of acquired QT prolongation. 1
Medication-Related Causes
High-Risk Medications
- Antiarrhythmic agents: Particularly Class IA (quinidine, procainamide, disopyramide) and Class III (sotalol, dofetilide, ibutilide, amiodarone) 2
- Antimicrobials:
- Psychiatric medications:
- Gastrointestinal medications:
- Other medications:
Multiple QT-prolonging medications have an additive effect, with each additional QT-prolonging drug adding approximately 3-11 ms to the QTc interval 5.
Electrolyte Abnormalities
- Hypokalemia: Very strong evidence for QT prolongation 6
- Hypomagnesemia: Commonly seen in patients with vomiting or diarrhea 2
- Hypocalcemia: Produces distinctive lengthening of the ST segment 2
Cardiac Conditions
- Heart disease: Especially left ventricular hypertrophy, ischemia, or low left ventricular ejection fraction 2
- Bradyarrhythmias: Including complete heart block and sinus pauses 2
- Myocardial infarction 1
- Heart failure 1
Other Medical Conditions
- Central nervous system abnormalities 2, 1
- Thyroid disease: Particularly hypothyroidism 1
- Renal failure 1
- Hepatic failure 1
- Autoimmune diseases: With anti-Ro/SSA antibodies (in neonates) 2, 1
Patient-Specific Risk Factors
- Female sex: Women have QTc intervals approximately 16 ms longer than men 5, 2
- Advanced age: QTc interval increases with age 5, 2
- Genetic predisposition: Congenital Long QT Syndrome (LQTS) 2
- Recent conversion from atrial fibrillation 1
Drug Overdose Considerations
- Opiates: Particularly methadone can cause QT prolongation 2
- Cocaine: Prolongs QT interval for several days after ingestion 2
- Psychotropic drugs: Overdose of tricyclic antidepressants or thioridazines 2
Risk Factors for Progression to Torsades de Pointes
QT prolongation can lead to torsades de pointes, a life-threatening ventricular arrhythmia, particularly when:
- QTc exceeds 500 ms 1
- Sudden bradycardia or long pauses occur 2
- T wave alternans or polymorphic ventricular premature beats develop 2
- Short-long-short cycle length sequences occur 2
Clinical Implications
- Monitor QT interval in the same ECG lead over time 2
- Document QTc before initiating QT-prolonging drugs and at least every 8 hours thereafter 2
- In patients who develop QTc >500 ms, discontinue the offending drug and continue ECG monitoring until QTc decreases 2
- Be particularly vigilant with patients who have multiple risk factors for QT prolongation 7
- Consider alternative medications with similar efficacy but lower risk of QT prolongation when appropriate 1
The combination of multiple QT-prolonging factors significantly increases the risk of torsades de pointes, making it essential to identify and address all modifiable risk factors 7.